The Disease Susceptibility Genetic Test-Anti-Cancer Package C

Name: The Disease Susceptibility Genetic Test-Anti-Cancer Package C
Brand: CapitalBio Technology Co., Ltd.

This test is based on biochip technology. By detecting TP53[Tumor suppressor gene], CYP1A1[Toxic metabolizing enzyme gene] and XRCC1[DNA damage repair gene], assessing their impact on the risk of tumors, reminding customers to conduct comprehensive genetic testing, and helping customers for early prevention.

Inquire Now

Features of the Disease Susceptibility Genetic Test-Anti-Cancer Package C

Test Content:

Male [11 items]	Lung cancer, liver cancer, stomach cancer, esophageal cancer, colorectal cancer, bladder
	cancer, nasopharyngeal cancer, thyroid cancer, lymphoma, skin cancer, prostate cancer
Femail [14 items]	Lung cancer, liver cancer, gastric cancer, esophageal cancer, colorectal cancer, bladder
	cancer, nasopharyngeal cancer, thyroid cancer, lymphoma, breast cancer, cervical cancer, ovarian cancer, skin cancer, endometrial cancer

Applicable Population of the Disease Susceptibility Genetic Test-Anti-Cancer Package C

People with bad eating habits, such as: like eating high-fat, high-calorie, pickled, smoked, fried foods.
People who smoke, who have been exposed to secondhand smoke for a long time, and who drink excessively.
People with irregular life and rest, long-term insomnia or staying up late, and lack of exercise.
People with long-term mental stress, anxiety, tension, irritability.
Overweight, obese people.

Specification of the Disease Susceptibility Genetic Test-Anti-Cancer Package C

Sample types	Venous blood / Oral swab
TAT	9 working days

Products

Related Solutions for Precise Healthcare Management Documents

Portable Full-automatic Intelligent Biochemical Analysis System

Click To View

PGS

Click To View